Read this study to learn about the increasing role of biologic therapies in the treatment of rheumatoid arthritis. International Journal of Clinical Rheumatology
David A. Fox, MD, President, ACR, provides expert commentary to Medscape on the new collaborative initiative between the ACR and EULAR. Medscape Rheumatology
Jonathan Kay, MD, summarizes the latest updates with tumor necrosis factor inhibitor for the treatment of RA, as illustrated by data from EULAR 2008. Medscape Rheumatology
The risk of malignancies in patients with rheumatoid arthritis has raised some concern, particularly with immunosuppressive approaches to disease management. Arthritis Research & Therapy